Leading the way in discovering biomarkers for personalized diagnosis/treatment
It is possible to select drugs / discover biomarkers / select druggable targets by synthesizing and analyzing cancer patient-derived organoids and patient clinical information
Organoid BankingBanking organoids successfully cultured from cancers of actual patients
We have established a biobank of approximately 230 cases of highly characterized organoids, derived from tumor tissue,
pleural effusion, and ascites samples across 9 different types of cancer.
Our organoid bank includes 156 colorectal cancer organoids, 27 lung cancer organoids, and 25 gastric cancer organoids
